Salute e Benessere
Swiss Health Tech Startup Aktiia Names Industry Veteran Rags Gupta as new CEO as Part of Global Push to Transform Blood Pressure Monitoring and Management
"Aktiia's mission to reduce the impact of blood pressure on global health is deeply personal. Add to this the novel technology that's already achieved product market fit and improved patient outcomes, the unique dataset, and the talented, dedicated team, and it makes for a once-in-career opportunity. I'm thrilled to join at such an inflection point in the business," said Rags Gupta. "It's time to scale."
Aktiia's CE-marked continuous blood pressure monitor is currently available in seven European markets. Earlier this year, Aktiia received CE approval for its next-generation CALFREE(tm) technology, which utilizes optical sensors that do not require calibration with a traditional cuff. This significantly improves user convenience and adaptability for various third-party devices, while still meeting the stringent BP accuracy and precision thresholds to be medically valid. Additional regulatory submissions are underway in markets, including the U.S.
Built on 20+ years of research, Aktiia's technology provides unparalleled innovation and ease in blood pressure data collection and machine learning modelling, offering personalized, continuous, and medical-grade blood pressure and heart rate data. Aktiia empowers people, researchers, and clinicians with unique blood pressure data, paving the way for novel understanding and personalized patient care of hypertension.
"Rags' strategic vision, entrepreneurial track record and ability to operate across cultures and domains stood out to us during our search process, and we're thrilled to have him join at an inflection point for our business," said Daniel Graf, President and Board member.
"From the time we spent together, it was clear that Rags had the strategic insight, operational experience and cultural fluency to be our next CEO," said Aktiia co-founder Mattia Bertschi , who will remain as COO. "We are proud to have him on board as our recent regulatory wins, ongoing research, and real-world adoption drive the next phase of Aktiia's growth."
Aktiia's mission has never been more critical, with over 1.4 billion people, worldwide, affected by high blood pressure, resulting in more than 18 million related deaths annually. The company is dedicated to changing the paradigm of blood pressure management, making it more accessible, accurate, and actionable for people worldwide.
For more information about Aktiia, please visit Aktiia's website.
Founded in Switzerland in May 2018 , Aktiia was created out of a passion for developing the best products for diagnosing and treating hypertension. Founders Drs. Mattia Bertschi (CEO) and Josep Solà (CTO) spent 15 years at the prestigious Swiss research institute, CSEM, deciphering the language of the heart to deepen their understanding of blood pressure. Today, Aktiia's global, diverse team of over 50 extraordinary individuals combines years of innovative research with AI model training and fine-tuning from a unique, growing dataset into a worldwide healthcare solution, offering the most complete and intuitive blood pressure monitoring and management tools on the market.
The full media package can be downloaded here.
Media Contact: Assad Khan
Email: press@aktiia.com
View original content:https://www.prnewswire.co.uk/news-releases/swiss-health-tech-startup-aktiia-names-industry-veteran-rags-gupta-as-new-ceo-as-part-of-global-push-to-transform-blood-pressure-monitoring-and-management-302212311.html